David Steinberg
Stock Analyst at Jefferies
(2.84)
# 1,740
Out of 4,876 analysts
35
Total ratings
59.26%
Success rate
20.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $6.46 | +23.84% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $26.54 | +137.38% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $31.16 | +28.37% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $106.90 | +75.87% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $9.22 | -13.23% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $3.87 | +210.08% | 2 | Jun 14, 2018 | |
| SVRA Savara | Initiates: Buy | $20 | $2.21 | +804.98% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $6.46
Upside: +23.84%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $26.54
Upside: +137.38%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $31.16
Upside: +28.37%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $106.90
Upside: +75.87%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $9.22
Upside: -13.23%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $3.87
Upside: +210.08%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $2.21
Upside: +804.98%